Skip to main content

Day: November 21, 2022

180 Life Sciences to Participate in A.G.P.’s Virtual Biotech Conference to be Held November 30 – December 1, 2022

PALO ALTO, Calif., Nov. 21, 2022 (GLOBE NEWSWIRE) — 180 Life Sciences Corp. (NASDAQ: ATNF) (“180 Life Sciences” or the “Company”), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that the Company will participate in A.G.P.’s Virtual Biotech Conference to be held November 30 – December 1, 2022. Dr. James Woody, President & Chief Executive Officer, will present a business and scientific overview of 180 Life Sciences, with availability for one-on-one and group meetings during the conference. Details can be found below: Date: November 30 – December 1, 2022Location: VirtualEvent Website: https://www.meetmax.com/sched/event_85817/conference_home.html?bank_access=0&event_id=85817 About 180 Life Sciences Corp. 180...

Continue reading

REPEAT – Alkaline Fuel Cell Power Corp. Closes Convertible Note Financing

TORONTO, Nov. 21, 2022 (GLOBE NEWSWIRE) — Alkaline Fuel Cell Power Corp. (NEO: PWWR) (OTCQB:ALKFF) (Frankfurt: 77R, WKN: A3CTYF) (“AFCP” or the “Company”), a diversified investment platform developing affordable, renewable, and reliable energy assets and cleantech, is pleased to the closing of a convertible note (the “Convertible Note”) financing in an aggregate amount C$4,000,000 (the “Financing”). “We are pleased with the support of our investors for this Financing,” said Frank Carnevale, Chief Executive Officer. “The Financing will assist with our working capital and allow the Company to focus on developing affordable renewable energy projects.” The Convertible Notes allow the Company to access up to C$4,000,000 on an aggregate basis and can be drawn on at the request of the Company. The Convertible Notes will mature November...

Continue reading

Millrock Provides Exploration Update on Fairbanks Gold District Projects, Alaska

Highlights:Treasure Creek project NW Array prospect drill results: Hole 22TCRC078: 89.9 meters grading 0.97 grams per tonne gold from 45.7 meters, including 41.1 meters grading 1.72 grams per tonne gold from 59.4 meters. The mineralized area now measures 400 meters by 750 meters and is open in four directions. Treasure Creek project Eastgate–Scrafford prospect drill results: Hole 22TCRC036: 7.6 meters grading 6.48 grams per tonne gold from 50.3 meters, including 1.5 meters grading 31.4 grams per tonne gold from 50.3 meters. Results pending: Assays from a further 90 holes drilled on various project areas on the Fairbanks Gold District properties are still pending from the assay laboratory. VANCOUVER, British Columbia, Nov. 21, 2022 (GLOBE NEWSWIRE) — Millrock Resources Inc. (TSX-V: MRO, OTCQB: MLRKF) (“Millrock” or the...

Continue reading

Triterras Schedules First Half Fiscal 2023 Conference Call for Wednesday, November 30, 2022 at 8:15 a.m. ET

SINGAPORE, Nov. 21, 2022 (GLOBE NEWSWIRE) — Triterras Inc. (OTC Expert Market: TRIRF) (“Triterras” or the “Company”), a leading fintech company focused on trade and trade finance, plans to release results for the first half of fiscal 2023 covering the six-months ended August 31, 2022 before the market opens on November 30, 2022. The Company will hold a conference call on Wednesday, November 30, 2022 at 8:15 am Eastern Time where management will provide a business and operational update during the call. Triterras management will host the presentation, followed by a question-and-answer period. Interested parties may submit questions in advance of the conference call by emailing IR@triterras.com. Date: Wednesday, November 30, 2022Time: 8:15 a.m. Eastern time (5:15 a.m. Pacific time)U.S. dial-in: (877) 407-0784International dial-in:...

Continue reading

Hepsiburada to Announce Third Quarter 2022 Results on December 6, 2022

ISTANBUL, Turkey, Nov. 21, 2022 (GLOBE NEWSWIRE) — D-MARKET Electronic Services & Trading (d/b/a “Hepsiburada”) (NASDAQ: HEPS), a leading Turkish e-commerce platform, will report its unaudited financial results for the third quarter ending September 30, 2022 before the U.S. market opens on Tuesday, December 6, 2022. Conference Call and Webcast DetailsThe Company’s management will host an analyst and investor conference call and live webcast to discuss its financial results at 16.00 İstanbul / 13.00 London / 8.00 a.m. New York time on Tuesday, December 6, 2022. Live webcast can be accessed via https://87399.themediaframe.eu/links/hepsiburada221206.html A replay will be available on the Hepsiburada Investor Relations website https://investors.hepsiburada.com following the call. The Company’s results presentation will be...

Continue reading

Newtek Receives Approval from the Federal Reserve to Become a Bank Holding Company 

BOCA RATON, Fla., Nov. 21, 2022 (GLOBE NEWSWIRE) — Newtek Business Services Corp. (NASDAQ: NEWT) (“Newtek”) today announced that it has received approval from the Federal Reserve to become a bank holding company and a financial holding company by acquiring the National Bank of New York City (“NBNYC”). The pending acquisition of NBNYC remains subject to the approval of the Office of the Comptroller of the Currency (“OCC”), which approval is currently anticipated in the coming weeks. The approval of the Federal Reserve is conditioned on the representations and commitments made by Newtek in connection with its applications, including the discontinuance of Newtek’s election to be regulated under the Investment Company Act of 1940 and to divest activities of certain of Newtek’s technology portfolio companies within two years of becoming...

Continue reading

Cellectar Biosciences Announces Presentation of Data on CLR 12120 Series of Targeted Alpha-Emitting Therapies at the 13th Annual World ADC Conference

Preclinical data demonstrate ability to deliver targeted alpha-emitting isotopes to malignant cells and therapeutic efficacy FLORHAM PARK, N.J., Nov. 21, 2022 (GLOBE NEWSWIRE) — Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced the presentation of preclinical data at the 13th Annual World ADC Conference supporting development of CLR 12120 series of targeted alpha therapies (TATs). The data demonstrate the versatility of the phospholipid ether (PLE) targeting platform and highlight the potential of the company’s alpha emitting precision medicines. The presentation entitled: “Novel Conjugates – Radiotherapies,” given by Cellectar’s Chief Operating Officer, Jarrod Longcor,...

Continue reading

DIGITAL UTILITIES VENTURES, INC ANNOUNCES STRATEGIC UPDATES

Easy Energy Systems, Inc. Easy FENBoston, Massachusetts, Nov. 21, 2022 (GLOBE NEWSWIRE) — Digital Utilities Ventures, Inc. (OTC: DUTV), announces an update for current and potential investors on the current status of DUTV, Easy Energy Systems, Inc., and Easy Energy Finance, as well as to clarify some potential confusion. Easy Energy Financing, Inc. Easy Energy Finance, Inc.  initiated in the Spring of 2022 the  creation of a Reg D and Reg S exempt security to raise capital.   The purpose of this capital is to be utilized to purchase modular equipment from Easy Energy Systems, Inc. , Easy Modular Manufacturing, Inc and the  other subsidiaries of DUTV.  This equipment will then be leased to end customers in the form of an operating lease  via a revenue share agreement to end user customers  with waste streams.    The end result...

Continue reading

Apollo Closes on $2.4 Billion for Inaugural Accord+ Fund

Commitments Bring Total Fundraising for Accord Family of Funds to Approx. $11bn Since Inception NEW YORK, Nov. 21, 2022 (GLOBE NEWSWIRE) — Apollo (NYSE: APO) today announced that it has closed on $2.4 billion in commitments for the Apollo Accord+ Fund (“Accord+”), its commingled multi-asset opportunistic credit offering. These new commitments bring total fundraising for the overarching Accord strategy to approximately $11 billion since inception, of which approximately $4.5 billion was raised in the past 12 months. Accord+, a closed-end fund, follows a multi-asset opportunistic credit strategy, investing in Apollo’s highest conviction themes from across its Credit platform. The fund primarily targets performing, dislocated, privately originated and asset-backed credit opportunities centered on what Apollo believes represents the...

Continue reading

Large Provider Network Adds Streamline Health®’s RevID™ Solution

National Health Systems Seeks Automated Charge Reconciliation for Improved Financial Performance Atlanta, GA, Nov. 21, 2022 (GLOBE NEWSWIRE) — Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced today an expansion of its existing relationship with a Southwest-based healthcare system with more than 60 acute care facilities in the United States. Building on the successful implementation of Streamline’s Compare™ tool, the health system has chosen to implement RevID’s automated charge reconciliation in six initial facilities to improve revenue integrity and financial performance. Streamline Health is leading an industry movement to improve hospital financial performance through pre-bill technology solutions. RevID’s automated...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.